4//SEC Filing
Grossi Federico 4
Accession 0001127602-22-020150
CIK 0001492422other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:18 PM ET
Size
4.5 KB
Accession
0001127602-22-020150
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-08-01$55.99/sh−2,500$139,975→ 107,384 total
Footnotes (2)
- [F1]This is a scheduled sale from 10b5-1 trading plan.
- [F2]Includes 323 shares from 4/30/2022 ESPP purchase.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720634
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:18 PM ET
- Size
- 4.5 KB